elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q44090999-E55754F6-D75B-4FC5-8EAE-C7799E2C20B8
Q44090999-E55754F6-D75B-4FC5-8EAE-C7799E2C20B8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q44090999-E55754F6-D75B-4FC5-8EAE-C7799E2C20B8
A public-private partnership to unlock the untargeted kinome.
P2860
Q44090999-E55754F6-D75B-4FC5-8EAE-C7799E2C20B8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q44090999-E55754F6-D75B-4FC5-8EAE-C7799E2C20B8
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
408b082c7561a2299c44a6aa38def5836d627fa8
P2860
Life beyond kinases: structure-based discovery of sorafenib as nanomolar antagonist of 5-HT receptors.